48
Participants
Start Date
July 31, 2012
Primary Completion Date
February 28, 2013
Study Completion Date
October 31, 2013
RBP-6000
single dose of RBP-6000, preceded by a pharmacokinetic (PK) sample followed by serial PK samples post-dose. Additionally subjects to remain in the clinic through Day 21 for safety assessments
Suboxone
RBP-6000 injection after 7 days of SL Suboxone administration. Interventions as above with additional daily PK collections during Suboxone treatment prior to RBP-6000 administration
Vince and Associates Clinical Research, Overland Park
Lead Sponsor
Indivior Inc.
INDUSTRY